Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.
Gaudin O, Seta V, Alexandre M, Bohelay G, Aucouturier F, Mignot-Grootenboer S, Ingen-Housz-Oro S, Bernardeschi C, Schneider P, Mellottee B, Caux F, Prost-Squarcioni C. Gaudin O, et al. Front Immunol. 2018 May 24;9:1030. doi: 10.3389/fimmu.2018.01030. eCollection 2018. Front Immunol. 2018. PMID: 29881377 Free PMC article.
Cross-reactivity in beta-lactams after a non-immediate cutaneous adverse reaction: experience of a reference centre for toxic bullous diseases and severe cutaneous adverse reactions.
Bérot V, Gener G, Ingen-Housz-Oro S, Gaudin O, Paul M, Chosidow O, Wolkenstein P, Assier H. Bérot V, et al. Among authors: gaudin o. J Eur Acad Dermatol Venereol. 2020 Apr;34(4):787-794. doi: 10.1111/jdv.15986. Epub 2019 Oct 28. J Eur Acad Dermatol Venereol. 2020. PMID: 31571276
Relapsing generalized bullous fixed drug eruption: A severe and avoidable cutaneous drug reaction. Three case reports.
Braesch C, Weill A, Gaudin O, Lebrun-Vignes B, Bernigaud C, Hua C, Ortonne N, Nakad L, Chambrin V, Chosidow O, Wolkenstein P, Thomas L, Assier H, Ingen-Housz-Oro S. Braesch C, et al. Among authors: gaudin o. Therapie. 2022 May-Jun;77(3):378-381. doi: 10.1016/j.therap.2021.04.004. Epub 2021 Apr 16. Therapie. 2022. PMID: 33962797 No abstract available.
Iloprost: a potential alternative for skin graft-resistant hypertensive leg ulcer.
Bonigen J, Gaudin O, Tella E, Hua C, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Mahé E, Senet P. Bonigen J, et al. Among authors: gaudin o. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e726-e728. doi: 10.1111/jdv.16547. Epub 2020 May 27. J Eur Acad Dermatol Venereol. 2020. PMID: 32349170 No abstract available.
Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched Analyses.
Poizeau F, Gaudin O, Le Cleach L, Duong TA, Hua C, Hotz C, Ingen-Housz-Oro S, Sbidian E, Zehou O, Colin A, de Prost N, Lebrun-Vignes B, Chosidow O, Wolkenstein P, Fardet L. Poizeau F, et al. Among authors: gaudin o. J Invest Dermatol. 2018 Jun;138(6):1293-1300. doi: 10.1016/j.jid.2017.12.034. Epub 2018 Jan 31. J Invest Dermatol. 2018. PMID: 29369774 Free article.
Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases.
Brin C, Bernigaud C, Hua C, Duong TA, Gaudin O, Colin A, de Prost N, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S. Brin C, et al. Among authors: gaudin o. Ann Dermatol Venereol. 2021 Sep;148(3):168-171. doi: 10.1016/j.annder.2021.02.002. Epub 2021 Apr 12. Ann Dermatol Venereol. 2021. PMID: 33858692 Clinical Trial.
Lupus erythematosus and epidermal necrolysis: a case series of 16 patients.
Gaudin O, Milpied B, Papouin B, Hüe S, Ortonne N, Régnier E, Wolkenstein P, Chosidow O, de Prost N, Ingen-Housz-Oro S. Gaudin O, et al. Br J Dermatol. 2022 Feb;186(2):372-374. doi: 10.1111/bjd.20775. Epub 2021 Nov 15. Br J Dermatol. 2022. PMID: 34597413 No abstract available.
100 results